
Cardiff Oncology, Inc.
CRDFNasdaqCIK 1213037HealthcareFiscal year ends Dec 31
Reports and events: 516 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-11-1216:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-458500 |
| 2026-11-1216:20 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001193125-26-458485 |
| 2026-10-2716:44 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-048720 |
| 2026-10-2216:30 ET | 8-K | 5.07 Shareholder vote results | 0001493152-26-048111 |
| 2026-09-1409:28 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-042506 |
| 2026-08-2616:01 ET | DEF 14A | Proxy statementPeriod 2026-08-26 | 0001193125-26-368249 |
| 2026-08-1116:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-344645 |
| 2026-08-1116:01 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-344545 |
| 2026-07-1608:38 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-305467 |
| 2026-06-1116:15 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-267563 |
| 2026-06-0308:30 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-26-254658 |
| 2026-05-2917:11 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-26-248711 |
| 2026-05-1917:01 ET | 8-K | 8.01 Other events | 0001193125-26-231040 |
| 2026-05-1416:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213037-26-000013 |
| 2026-05-1416:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213037-26-000011 |
| 2026-04-2316:44 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001213037-26-000006 |
| 2026-04-0916:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-149623 |
| 2026-04-0216:15 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors | 0001193125-26-140152 |
| 2026-02-2508:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-068668 |
| 2026-02-2417:09 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001193125-26-067476 |
| 2026-02-2417:07 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-067464 |
| 2026-01-2716:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-024375 |
| 2025-11-0616:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269492 |
| 2025-11-0616:00 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269424 |
| 2025-07-2916:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events | 0000950170-25-099631 |
| 2025-07-2916:00 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-099610 |
| 2025-06-2616:30 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-016659 |
| 2025-06-1716:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-087369 |
| 2025-05-0816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066947 |
| 2025-05-0816:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066886 |
| 2025-04-2916:00 ET | DEF 14A | Proxy statementPeriod 2025-04-29 | 0000950170-25-060074 |
| 2025-02-2716:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-029065 |
| 2025-02-2716:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-028992 |
| 2025-01-0616:10 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-002076 |
| 2024-12-1016:10 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-134970 |
| 2024-12-1006:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-134749 |
| 2024-11-0716:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123303 |
| 2024-11-0716:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123242 |
| 2024-08-0816:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-036122 |
| 2024-08-0816:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-036098 |
| 2024-06-2016:03 ET | 8-K | 5.07 Shareholder vote results | 0001628280-24-029108 |
| 2024-06-0316:03 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-026295 |
| 2024-05-0216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-020010 |
| 2024-05-0216:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-019974 |
| 2024-04-2516:02 ET | DEF 14A | Proxy statementPeriod 2024-06-20 | 0001628280-24-018143 |
| 2024-04-0816:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-015247 |
| 2024-02-2916:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-007972 |
| 2024-02-2916:00 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-007948 |
| 2024-01-0809:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-000780 |
| 2023-11-0216:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-036386 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:10 ET. Listed shows no prices and gives no investment advice.